EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis

Samuel H Sigal, Arun J Sanyal, R Todd Frederick, Ethan M Weinberg, S Chris Pappas, Khurram Jamil

Clinical Gastroenterology and Hepatology · 2023

DOI: 10.1016/j.cgh.2023.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023. Verfasst von Samuel H Sigal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York. Electronic address: …. Hauptthemen laut MEDLINE: Hepatorenal Syndrome, Hepatitis, Alcoholic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mallinckrodt Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcoholic hepatitis (AH) develops after extended periods of excessive alcohol consumption and frequently leads to cirrhosis and liver failure.1 Patients with severe AH—defined by a Maddrey discriminant function (MDF) score of ≥32—often develop acute kidney injury (AKI), which is associated with dismal outcomes. In a study of 103 patients with AH, 28% developed AKI, and 3-month survival was reduced to 35% vs 93% for those without AKI.2 Vasoconstrictor therapy plus albumin is an effective treatment for hepatorenal syndrome (HRS).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatorenal SyndromeHepatitis, AlcoholicHumansTerlipressinVasoconstrictor AgentsTreatment OutcomeLypressinAlbumins

Substanzen

TerlipressinVasoconstrictor AgentsLypressinAlbumins

Autor:innen und Institutionen

  • Division of Hepatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York. Electronic address: ssigal@montefiore.org.
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
  • Department of Transplant, California Pacific Medical Center, San Francisco, California.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Clinical Development and Scientific Affairs, Orphan Therapeutics, LLC, Longboat Key, Florida.
  • Department of Scientific Affairs, VP of Hepatology, Mallinckrodt Pharmaceuticals, Hampton, New Jersey.

Förderung

  • Mallinckrodt Pharmaceuticals

Zitieren

APA

Sigal, S. H., Sanyal, A. J., Frederick, R. T., Weinberg, E. M., Pappas, S. C., & Jamil, K. (2023). Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.02.015

Vancouver

Sigal SH, Sanyal AJ, Frederick RT, Weinberg EM, Pappas SC, Jamil K. Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology. 2023. doi:10.1016/j.cgh.2023.02.015

BibTeX
@article{Sigal2023,
  author = {Sigal, Samuel H and Sanyal, Arun J and Frederick, R Todd and Weinberg, Ethan M and Pappas, S Chris and Jamil, Khurram},
  title = {Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1016/j.cgh.2023.02.015}
}
Kostenlos starten →